Briony Hazelton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Briony Hazelton has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- David Anthony Foley
PathWest Laboratory Medicine Nedlands Western Australia Australia
2 shared publications - Andrew James Stewardson
Department of Infectious Diseases, The Alfred Hospital and School of Translational Medicine, Monash University, Melbourne, Australia
1 shared publication - Andrew Walczak
PathWest Laboratory Medicine, QEII, Nedlands, WA, Australia
1 shared publication - Avram Levy
Department of Microbiology, PathWest Laboratory Medicine WA, Nedlands, Western Australia, Australia
1 shared publication - Barry Tam
Health Infrastructure NSW, 60 Day Road, Cheltenham, NSW, 2119, Australia
1 shared publication - Breanne Emily Kunstler
BehaviourWorks Australia, Monash Sustainable Development Institute, Monash University, Clayton, VIC, Australia
1 shared publication
Latest Publications
- Open Access
Respiratory Syncytial Virus Reinfections in Children in Western Australia
Respiratory syncytial virus (RSV) reinfection in children is poorly understood. We examined the incidence, characteristics, and outcomes of hospital-attended RSV reinfections in children <16 years in Western Australia between 2012 and 2022. Individuals with repeat RSV detections ≥56 days apart were identified using laboratory data. The incidence of reinfection in the first five years of life was estimated using the total birth population from 2012 to 2017. Clinical data on a subset of reinfection episodes were obtained from two metropolitan pediatric centers. A total of 466 children with hospital-attended reinfections were identified. The median interval between RSV detections was 460 days (interquartile range: 324, 812), with a reinfection rate of 95 per 100,000 individuals (95% confidence interval: 82, 109). Reinfection was most common in children who experienced their first RSV detection <6 months of age. Predisposing factors were identified in 56% of children; children with predisposing factors were older at first and second detections, were more likely to be admitted, and had a longer length of stay. This study highlights the significant burden of hospital-attended RSV reinfections in children with and without predisposing factors. Expanded surveillance with in-depth clinical data is required to further characterize the impact of RSV reinfection.
Open AccessRespiratory Syncytial Virus Reinfections in Children in Western Australia
Respiratory syncytial virus (RSV) reinfection in children is poorly understood. We examined the incidence, characteristics, and outcomes of hospital-attended RSV reinfections in children <16 years in Western Australia between 2012 and 2022. Individuals with repeat RSV detections ≥56 days apart were identified using laboratory data. The incidence of reinfection in the first five years of life was estimated using the total birth population from 2012 to 2017. Clinical data on a subset of reinfection episodes were obtained from two metropolitan pediatric centers. A total of 466 children with hospital-attended reinfections were identified. The median interval between RSV detections was 460 days (interquartile range: 324, 812), with a reinfection rate of 95 per 100,000 individuals (95% confidence interval: 82, 109). Reinfection was most common in children who experienced their first RSV detection <6 months of age. Predisposing factors were identified in 56% of children; children with predisposing factors were older at first and second detections, were more likely to be admitted, and had a longer length of stay. This study highlights the significant burden of hospital-attended RSV reinfections in children with and without predisposing factors. Expanded surveillance with in-depth clinical data is required to further characterize the impact of RSV reinfection.
- 28 June 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (3) , 106903
Treating carbapenemase-producing Enterobacterales urosepsis with ceftazidime/avibactam in pregnancy
- 28 June 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (3) , 106903
Treating carbapenemase-producing Enterobacterales urosepsis with ceftazidime/avibactam in pregnancy
- Open Access
- 20 January 2022
- Published by Elsevier in Infection, Disease & Health
- Vol. 27 (2) , 81-95
P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects
- 20 January 2022
- Published by Elsevier in Infection, Disease & Health
- Vol. 27 (2) , 81-95
Open AccessP2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects